Studies have found that high concentrations of propofol enhance the cytotoxicity of paclitaxel against cervical cancer cells by down-regulating stathmin 1 expression, but clinical concentrations of propofol may not have this effect (Jin et al., 2023). Here, STMN1 is linked to cervical carcinoma.